Acute pancreatitis in the critical care setting: A review of assessment and intervention strategies

Abstract

The incidence of acute pancreatitis (AP), a condition characterized by inflammation in the pancreas, has been increasing globally and is associated with several complications. This review elaborated on the etiology, clinical presentation, severity assessment, and treatment modalities of AP, mainly in the critical care setting. Patients with severe AP, as indicated by organ failure (>48 hours from onset), warrant treatment in the intensive care unit setting. The most common etiologies, biliary disease and alcohol consumption, and the advanced diagnostic tools used for the identification of the cause are highlighted. Different severity assessment tools are utilized for grading the severity of the disease, predicting patient outcomes, determining the associated risk, and guiding treatment decisions. The treatment interventions comprise various approaches, such as anti-infective therapy enteral nutrition, analgesics for pain, or minimally invasive surgical procedures, thereby demonstrating an evolving landscape of AP management. Furthermore, various complications such as necrosis, organ failure, and hemorrhage, necessitate disease monitoring and differential diagnosis and are crucial for optimal management of patients. Novel treatment modalities and advancements in multidisciplinary care emphasize the potential for reducing the burden of AP in critical care settings.

Keywords

Acute pancreatitis / Critical care / Intensive care unit / Necrotizing pancreatitis / Organ failure

References

[1] Aljiffry MM, Alhazmi MF, Abu Alqam R, Takieddin SZ, Abulfaraj M. Epidemiological features of acute pancreatitis (AP): Largest single—center, cohort study in the Western Region of Saudi Arabia. Cureus 2023; 15(5): e38445.

[2] Gliem N, Ammer—Herrmenau C, Ellenrieder V, Neesse A. Management of severe acute pancreatitis: An update. Digestion 2021; 102(4): 503-507.

[3] Tenner S, Baillie J, DeWitt J, Vege SS, American College of Gastroenterology. American College of Gastroenterology guideline: Management of acute pancreatitis. Am J Gastroenterol 2013; 108(9): 1400—1415, 1416.

[4] Li CL, Jiang M, Pan CQ, Li J, Xu LG. The global, regional, and national burden of acute pancreatitis in 204 countries and territories, 1990—2019. BMC Gastroenterol 2021; 21(1): 332.

[5] Zubia—Olaskoaga F, Maraví—Poma E, Urreta—Barallobre I, Ramírez—Puerta MR, Mourelo—Fariña M, Marcos—Neira MP, et al. Development and validation of a multivariate prediction model for patients with acute pancreatitis in intensive care medicine. Pancreatology 2018; 18(2): 161-167.

[6] Working Group IAP/APA Acute Pancreatitis Guidelines. IAP/APA evidence—based guidelines for the management of acute pancreatitis. Pancreatology 2013; 13(4 Suppl 2): e1-e15.

[7] Russell PS, Mittal A, Brown L, McArthur C, Phillips AJ, Petrov M, et al. Admission, management and outcomes of acute pancreatitis in intensive care. ANZ J Surg 2017; 87(12): E266-E270.

[8] Sundararajan K, Schoeman T, Hughes L, Edwards S, Reddi B. Predictors and outcomes of acute pancreatitis in critically ill patients presenting to the emergency department of a tertiary referral centre in Australia. Emerg Med Australas 2017; 29(2): 184-191.

[9] Ventre C, Nowell S, Graham C, Kidd D, Skouras C, Mole DJ. Survival and new—onset morbidity after critical care admission for acute pancreatitis in Scotland: A national electronic healthcare record linkage cohort study. BMJ Open 2018; 8: e023853.

[10] Hasibeder WR, Torgersen C, Rieger M, Dünser M. Critical care of the patient with acute pancreatitis. Anaesth Intensive Care 2009; 37(2): 190-206.

[11] Finkenstedt A, Jaber S, Joannidis M. Ten tips to manage severe acute pancreatitis in an intensive care unit. Intensive Care Med 2023; 49(9): 1127-1130.

[12] Husu HL, Leppäniemi AK, Lehtonen TM, Puolakkainen PA, Mentula PJ. Short— and long—term survival after severe acute pancreatitis: A retrospective 17 years' cohort study from a single center. J Crit Care 2019; 53: 81-86.

[13] Cole S, Wakeham M, Werlin S, Goday PS. Classification and nutrition management of acute pancreatitis in the pediatric intensive care unit. J Pediatr Gastroenterol Nutr 2018; 67(6): 755-759.

[14] Banks PA, Bollen TL, Dervenis C, Gooszen HG, Johnson CD, Sarr MG, et al. Classification of acute pancreatitis——2012: Revision of the Atlanta classification and definitions by international consensus. Gut 2013; 62(1): 102-111.

[15] Wu Q, Zhong X, Fu M, Yang H, Bo H, Liao X, et al. High—density lipoprotein cholesterol to low—density lipoprotein cholesterol ratio in early assessment of disease severity and outcome in patients with acute pancreatitis admitted to the ICU. BMC Gastroenterol 2020; 20: 164.

[16] Kang D, Park SH, Oh C, Kim YJ, Kim JB, Park SH, et al. Prevalence and prognosis of acute pancreatitis in critically ill patients with COVID—19. Hepatobiliary Pancreat Dis Int 2023; 22: 399-402.

[17] Basit H, Ruan GJ, Mukherjee S. Ranson criteria. Treasure Island (FL): StatPearls; 2024.

[18] Ferreira Ade F, Bartelega JA, Urbano HC, de Souza IK. Acute pancreatitis gravity predictive factors: Which and when to use them? Arq Bras Cir Dig 2015; 28(3): 207-211.

[19] Steinberg W, Tenner S. Acute pancreatitis. N Engl J Med 1994; 330(17): 1198-1210.

[20] Adiamah A, Kushairi A, Tumilty S, Na Y, Crook M, Brooks AJ, et al. Hypertriglyceridaemia as a risk factor for critical care admission in acute pancreatitis: A prospective study. Clin Nutr ESPEN 2020; 39: 227-233.

[21] Teng TZ, Tan JK, Baey S, Gunasekaran SK, Junnarkar SP, Low JK, et al. Sequential organ failure assessment score is superior to other prognostic indices in acute pancreatitis. World J Crit Care Med 2021; 10(6): 355-368.

[22] Baey S, Tan T, Gunasekaran SK, Junnarkar SP, Low JK, Huey CW, et al. Sequential organ failure assessment (SOFA) score is superior to classical prognostic indices in prediction of severity, intensive care unit admissions and mortality in acute pancreatitis. Hpb 2021; 23: S48-S49.

[23] Li C, Ren Q, Wang Z, Wang G. Early prediction of in—hospital mortality in acute pancreatitis: A retrospective observational cohort study based on a large multicentre critical care database. BMJ Open 2020; 10(12): e041893.

[24] Montravers P, Kantor E, Constantin JM, Lefrant JY, Lescot T, Nesseler N, et al. Epidemiology and prognosis of anti—infective therapy in the ICU setting during acute pancreatitis: A cohort study. Crit Care 2019; 23(1): 393.

[25] Siregar GA, Siregar GP. Management of severe acute pancreatitis. Open Access Maced J Med Sci 2019; 7(19): 3319-3323.

[26] Sun C, Li Z, Shi Z, Li G. Current diagnosis and treatment of acute pancreatitis in China: A real—world, multicenter study. BMC Gastroenterol 2021; 21(1): 210.

[27] van den Berg FF, Boermeester MA. Update on the management of acute pancreatitis. Curr Opin Crit Care 2023; 29(2): 145-151.

[28] Kumar V, Barkoudah E, Souza DA, Jin DX, McNabb—Baltar J. Clinical course and outcome among patients with acute pancreatitis and COVID—19. Eur J Gastroenterol Hepatol 2021; 33(5): 695-700.

[29] Kao SY, Chen TH, Wang CY, Hsiao CY, Chiang CS, Chou SC, et al. Surgical intervention strategies of necrotizing pancreatitis with abdominal compartment syndrome. Pancreas 2021; 50(10): 1415-1421.

[30] Mancilla Asencio C, Berger Fleiszig Z. Intra—abdominal hypertension: A systemic complication of severe acute pancreatitis. Medicina (Kaunas) 2022; 58(6): 785.

[31] Gapp J, Tariq A, Chandra S. Acute pancreatitis. Treasure Island (FL): StatPearls; 2024.

[32] Jabaudon M, Genevrier A, Jaber S, Windisch O, Bulyez S, Laterre PF, et al. Thoracic epidural analgesia in intensive care unit patients with acute pancreatitis: The EPIPAN multicenter randomized controlled trial. Crit Care 2023; 27(1): 213.

[33] Wang C, Zhang J, Liu L, Qin W, Luo N. Early predictive value of presepsin for secondary sepsis and mortality in intensive care unit patients with severe acute pancreatitis. Shock 2023; 59(4): 560-568.

[34] Lagoo JY, D'Souza MC, Kartha A, Kutappa AM. Role of Ulinastatin, a trypsin inhibitor, in severe acute pancreatitis in critical care setting: A retrospective analysis. J Crit Care 2018; 45: 27-32.

[35] Nambi D, Giridharan B. Comparison of Ranson’s and Glasgow criteria with revised Atlanta in prediction of mortality in acute pancreatitis patients. Int Surg J 2019; 6(5): 1629.

[36] Singh Walia B, Dugg P, Singh G, Sharma S, Singh Sandhu M. Evaluation of acute pancreatitis based on BISAP scoring system: A cohort study of 50 cases. Acta Med Martiniana 2022; 22(3): 144-154.

[37] Suvarna R, Pallipady A, Bhandary N, Hanumanthappa H. The clinical prognostic indicators of acute pancreatitis by APACHE II scoring. J Clin Diagn Res 2011; 5(3): 459-463.

[38] Chong B, Yu CY, Quezada M, Roy I, Da B, Yaghooti N, et al. PASS (Pancreatitis Activity Scoring System) predicts moderately severe and severe acute pancreatitis: 51. Am J Gastroenterol 2017; 112: S24.

[39] Harshit Kumar A, Singh Griwan M. A comparison of APACHE II, BISAP, Ranson's score and modified CTSI in predicting the severity of acute pancreatitis based on the 2012 revised Atlanta Classification. Gastroenterol Rep (Oxf) 2018; 6(2): 127-131.

[40] Vashistha A, Khandelwal RG, Om P, Rundla M. Assessing the efficacy of modified Marshall scoring system in severity assessment of acute pancreatitis in comparison to Ranson score at tertiary centre. Int Surg J 2023; 10(11): 1764-1770.